EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization

Yoshino Kawaguchi, Mari Kimura, Tatsuya Karaki, Hiroki Tanaka, Chikako Ono, Tatsuhiro Ishida iD, Yoshiharu Matsuura, Toshiro Hirai, Hidetaka Akita iD, Taro Shimizu, Yasuo Yoshioka iD

ACS Nano · 05.08.2025 · 19 (30) · 27977-28001

DOI: 10.1021/acsnano.5c10648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 23.07.2025. Verfasst von Yoshino Kawaguchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, The University of Osaka, …. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Lipids, mRNA Vaccines. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Osaka University, Takeda Science Foundation, BIKEN Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRNA, MessengerLipidsmRNA VaccinesAnimalsMicePolyethylene GlycolsFemaleMice, Inbred C57BLCD8-Positive T-LymphocytesNanovaccinesLiposomes

Stichwörter der Autor:innen

PEG-lipidscholesterollipid nanoparticlemRNA vaccinephospholipids

Substanzen

RNA, MessengerLipidsPolyethylene GlycolsLipid NanoparticlesmRNA VaccinesNanovaccinesLiposomes

Autor:innen und Institutionen

  • Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, The University of Osaka, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Department of Pharmacokinetics and Biopharmaceutics, Graduate School of Biomedical Sciences, Tokushima University, 1-78-1 Sho-machi, Tokushima, Tokushima 770-8505, Japan.
  • The Research Foundation for Microbial Diseases of Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan.
  • Center for Advanced Modalities and DDS, The University of Osaka, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Laboratory of Virus Control, Research Institute for Microbial Diseases, The University of Osaka, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.

ORCID-Profile: Tatsuhiro Ishida, Hidetaka Akita, Yasuo Yoshioka

Förderung

  • Osaka University
  • Takeda Science Foundation
  • BIKEN Foundation
  • Japan Agency for Medical Research and Development
  • Nippon Foundation
  • Japan Society for the Promotion of Science

Zitieren

APA

Kawaguchi, Y., Kimura, M., Karaki, T., Tanaka, H., Ono, C., Ishida, T., Matsuura, Y., Hirai, T., Akita, H., Shimizu, T., & Yoshioka, Y. (2025). Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization. ACS Nano, 19(30), 27977-28001. https://doi.org/10.1021/acsnano.5c10648

Vancouver

Kawaguchi Y, Kimura M, Karaki T, Tanaka H, Ono C, Ishida T, et al. Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization. ACS Nano. 2025;19(30):27977-28001. doi:10.1021/acsnano.5c10648

BibTeX
@article{Kawaguchi2025,
  author = {Kawaguchi, Yoshino and Kimura, Mari and Karaki, Tatsuya and Tanaka, Hiroki and Ono, Chikako and Ishida, Tatsuhiro and Matsuura, Yoshiharu and Hirai, Toshiro and Akita, Hidetaka and Shimizu, Taro and Yoshioka, Yasuo},
  title = {Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {30},
  pages = {27977--28001},
  doi = {10.1021/acsnano.5c10648}
}
Kostenlos starten →